Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir for Genotype 6 Hepatitis C
NCT01949168Phase 2Unknown
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of boceprevir in hepatitis C (HCV) (3 arms), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Early viral kinetics at Day 5. Status: unknown.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01949168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949168.